\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ no\\ treatment\\.\ \(2\)\
\-\ multiple\\ extra\\ spinal\\ neurofibromas\\ involving\\ lumbosacral\\ plexus\\.\\ \\ neurofibromas\\ are\\ isointense\\ with\\ muscle\\ on\\ t1\\ scans\\,\\ hyperintense\\ on\\ t2\\ scans\\,\\ and\\ do\\ not\\ enhance\\ to\\ any\\ significant\\ degree\\ after\\ gadolinium\\ contrast\\.\ \(0\)\
\-\ neurofibromatosis\\ type\\ 1\\ with\\ lumbosacral\\ plexus\\ involvement\\.\ \(0\)\
\-\ none\ \(204\)\
\-\ 14\\ y\\.o\\.\\ girl\\ with\\ known\\ diagnosis\\ \\.\\.\\.\\ routine\\ follow\\-up\\ imaging\\ of\\ spine\\.\\ \\ currently\\ no\\ symptoms\\.\ \(0\)\
\-\ this\\ teen\\ age\\ girl\\ had\\ a\\ known\\ prior\\ diagnosis\\ of\\ neurofibromatosis\\ type\\ i\\ and\\ this\\ was\\ a\\ routine\\ surveillance\\ exam\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ neurofibromas\\:\\ 0\\.3563385713995954\ \(0\)\
\-\ lumbosacral\\:\\ 0\\.2964186613694843\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.2780042452671483\ \(0\)\
\-\ plexus\\:\\ 0\\.2527462352087045\ \(0\)\
\-\ scans\\:\\ 0\\.24393933000903492\ \(0\)\
\-\ teen\\:\\ 0\\.22416441077885768\ \(0\)\
\-\ routine\\:\\ 0\\.2170994960917151\ \(0\)\
\-\ girl\\:\\ 0\\.19665663880695625\ \(0\)\
\-\ type\\:\\ 0\\.18806452525407105\ \(0\)\
\-\ known\\:\\ 0\\.1815020869990707\ \(0\)\
\-\ surveillance\\:\\ 0\\.15314033987544728\ \(0\)\
\-\ diagnosis\\:\\ 0\\.1453276082142684\ \(0\)\
\-\ isointense\\:\\ 0\\.12683676611718225\ \(0\)\
\-\ enhance\\:\\ 0\\.1254712680501156\ \(0\)\
\-\ degree\\:\\ 0\\.12255244272625831\ \(0\)\
\-\ extra\\:\\ 0\\.11774685013671218\ \(0\)\
\-\ gadolinium\\:\\ 0\\.11679553228266781\ \(0\)\
\-\ do\\:\\ 0\\.11618118423015028\ \(0\)\
\-\ hyperintense\\:\\ 0\\.11149964563046111\ \(0\)\
\-\ not\\:\\ 0\\.11067258326151795\ \(0\)\
\-\ currently\\:\\ 0\\.10767596204161237\ \(0\)\
\-\ 14\\:\\ 0\\.10465092092762251\ \(0\)\
\-\ involvement\\:\\ 0\\.10145285802890854\ \(0\)\
\-\ spinal\\:\\ 0\\.09953089048058247\ \(0\)\
\-\ muscle\\:\\ 0\\.09953089048058247\ \(0\)\
\-\ involving\\:\\ 0\\.09818205324449944\ \(0\)\
\-\ this\\:\\ 0\\.09633076020046302\ \(0\)\
\-\ available\\:\\ 0\\.09510217532814598\ \(0\)\
\-\ spine\\:\\ 0\\.09259695587053059\ \(0\)\
\-\ no\\:\\ 0\\.091164218168348\ \(0\)\
\-\ any\\:\\ 0\\.09058991084244371\ \(0\)\
\-\ age\\:\\ 0\\.08800092459385533\ \(0\)\
\-\ t1\\:\\ 0\\.08733547388888152\ \(0\)\
\-\ on\\:\\ 0\\.08466827217940541\ \(0\)\
\-\ with\\:\\ 0\\.08234187393468434\ \(0\)\
\-\ significant\\:\\ 0\\.08093181597291878\ \(0\)\
\-\ t2\\:\\ 0\\.0806444133731803\ \(0\)\
\-\ prior\\:\\ 0\\.07842608394989091\ \(0\)\
\-\ symptoms\\:\\ 0\\.07669379055547551\ \(0\)\
\-\ none\\:\\ 0\\.07660272445190615\ \(0\)\
\-\ imaging\\:\\ 0\\.07366475749811965\ \(0\)\
\-\ exam\\:\\ 0\\.07056229834286981\ \(0\)\
\-\ had\\:\\ 0\\.06983849123262295\ \(0\)\
\-\ multiple\\:\\ 0\\.06856082945190463\ \(0\)\
\-\ contrast\\:\\ 0\\.06810636869096913\ \(0\)\
\-\ after\\:\\ 0\\.06799939141205688\ \(0\)\
\-\ treatment\\:\\ 0\\.06677102395485468\ \(0\)\
\-\ and\\:\\ 0\\.05792936263058141\ \(0\)\
\-\ of\\:\\ 0\\.05486180270907707\ \(0\)\
\-\ are\\:\\ 0\\.053188630240945584\ \(0\)\
\-\ was\\:\\ 0\\.04885108291209571\ \(0\)\
\-\ to\\:\\ 0\\.03504254758198692\ \(0\)\
